The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prenatal Screening-Global Market Insights and Sales Trends 2025
Synopsis
The global Prenatal Screening market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Prenatal Screening in various end use industries. The expanding demands from the Hospitals, Gynecology Clinics and Research Organizations,, are propelling Prenatal Screening market. First-Trimester Screening Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Second-Trimester Screening Tests segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Prenatal Screening market, driven by demand from China, the second largest economy with some signs of stabilising, the Prenatal Screening market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prenatal Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prenatal Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prenatal Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prenatal Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prenatal Screening covered in this report include Laboratory Corporation of America Holdings, Sequenom, Quest Diagnostics, Illumina, GeneDx, Ariosa Diagnostics, Natera, Ravgen and Counsyl, etc.
The global Prenatal Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Laboratory Corporation of America Holdings
Sequenom
Quest Diagnostics
Illumina
GeneDx
Ariosa Diagnostics
Natera
Ravgen
Counsyl
Eurofins NTD
Premaitha Health
Prenatal Paternities
Global Prenatal Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prenatal Screening market, Segment by Type:
First-Trimester Screening Tests
Second-Trimester Screening Tests
Third-Trimester Screening Tests
Diagnostic Tests
Global Prenatal Screening market, by Application
Hospitals
Gynecology Clinics
Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prenatal Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Prenatal Screening market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Prenatal Screening in various end use industries. The expanding demands from the Hospitals, Gynecology Clinics and Research Organizations,, are propelling Prenatal Screening market. First-Trimester Screening Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Second-Trimester Screening Tests segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Prenatal Screening market, driven by demand from China, the second largest economy with some signs of stabilising, the Prenatal Screening market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prenatal Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prenatal Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prenatal Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prenatal Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prenatal Screening covered in this report include Laboratory Corporation of America Holdings, Sequenom, Quest Diagnostics, Illumina, GeneDx, Ariosa Diagnostics, Natera, Ravgen and Counsyl, etc.
The global Prenatal Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Laboratory Corporation of America Holdings
Sequenom
Quest Diagnostics
Illumina
GeneDx
Ariosa Diagnostics
Natera
Ravgen
Counsyl
Eurofins NTD
Premaitha Health
Prenatal Paternities
Global Prenatal Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prenatal Screening market, Segment by Type:
First-Trimester Screening Tests
Second-Trimester Screening Tests
Third-Trimester Screening Tests
Diagnostic Tests
Global Prenatal Screening market, by Application
Hospitals
Gynecology Clinics
Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prenatal Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prenatal Screening
1.1 Prenatal Screening Market Overview
1.1.1 Prenatal Screening Product Scope
1.1.2 Prenatal Screening Market Status and Outlook
1.2 Global Prenatal Screening Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prenatal Screening Market Size by Region (2018-2029)
1.4 Global Prenatal Screening Historic Market Size by Region (2018-2023)
1.5 Global Prenatal Screening Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prenatal Screening Market Size (2018-2029)
1.6.1 North America Prenatal Screening Market Size (2018-2029)
1.6.2 Europe Prenatal Screening Market Size (2018-2029)
1.6.3 Asia-Pacific Prenatal Screening Market Size (2018-2029)
1.6.4 Latin America Prenatal Screening Market Size (2018-2029)
1.6.5 Middle East & Africa Prenatal Screening Market Size (2018-2029)
2 Prenatal Screening Market by Type
2.1 Introduction
2.1.1 First-Trimester Screening Tests
2.1.2 Second-Trimester Screening Tests
2.1.3 Third-Trimester Screening Tests
2.1.4 Diagnostic Tests
2.2 Global Prenatal Screening Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prenatal Screening Historic Market Size by Type (2018-2023)
2.2.2 Global Prenatal Screening Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prenatal Screening Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prenatal Screening Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prenatal Screening Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prenatal Screening Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prenatal Screening Revenue Breakdown by Type (2018-2029)
3 Prenatal Screening Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Gynecology Clinics
3.1.3 Research Organizations
3.2 Global Prenatal Screening Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prenatal Screening Historic Market Size by Application (2018-2023)
3.2.2 Global Prenatal Screening Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prenatal Screening Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prenatal Screening Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prenatal Screening Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prenatal Screening Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prenatal Screening Revenue Breakdown by Application (2018-2029)
4 Prenatal Screening Competition Analysis by Players
4.1 Global Prenatal Screening Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prenatal Screening as of 2022)
4.3 Date of Key Players Enter into Prenatal Screening Market
4.4 Global Top Players Prenatal Screening Headquarters and Area Served
4.5 Key Players Prenatal Screening Product Solution and Service
4.6 Competitive Status
4.6.1 Prenatal Screening Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Laboratory Corporation of America Holdings
5.1.1 Laboratory Corporation of America Holdings Profile
5.1.2 Laboratory Corporation of America Holdings Main Business
5.1.3 Laboratory Corporation of America Holdings Prenatal Screening Products, Services and Solutions
5.1.4 Laboratory Corporation of America Holdings Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.1.5 Laboratory Corporation of America Holdings Recent Developments
5.2 Sequenom
5.2.1 Sequenom Profile
5.2.2 Sequenom Main Business
5.2.3 Sequenom Prenatal Screening Products, Services and Solutions
5.2.4 Sequenom Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.2.5 Sequenom Recent Developments
5.3 Quest Diagnostics
5.3.1 Quest Diagnostics Profile
5.3.2 Quest Diagnostics Main Business
5.3.3 Quest Diagnostics Prenatal Screening Products, Services and Solutions
5.3.4 Quest Diagnostics Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.3.5 Illumina Recent Developments
5.4 Illumina
5.4.1 Illumina Profile
5.4.2 Illumina Main Business
5.4.3 Illumina Prenatal Screening Products, Services and Solutions
5.4.4 Illumina Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.4.5 Illumina Recent Developments
5.5 GeneDx
5.5.1 GeneDx Profile
5.5.2 GeneDx Main Business
5.5.3 GeneDx Prenatal Screening Products, Services and Solutions
5.5.4 GeneDx Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.5.5 GeneDx Recent Developments
5.6 Ariosa Diagnostics
5.6.1 Ariosa Diagnostics Profile
5.6.2 Ariosa Diagnostics Main Business
5.6.3 Ariosa Diagnostics Prenatal Screening Products, Services and Solutions
5.6.4 Ariosa Diagnostics Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.6.5 Ariosa Diagnostics Recent Developments
5.7 Natera
5.7.1 Natera Profile
5.7.2 Natera Main Business
5.7.3 Natera Prenatal Screening Products, Services and Solutions
5.7.4 Natera Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.7.5 Natera Recent Developments
5.8 Ravgen
5.8.1 Ravgen Profile
5.8.2 Ravgen Main Business
5.8.3 Ravgen Prenatal Screening Products, Services and Solutions
5.8.4 Ravgen Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.8.5 Ravgen Recent Developments
5.9 Counsyl
5.9.1 Counsyl Profile
5.9.2 Counsyl Main Business
5.9.3 Counsyl Prenatal Screening Products, Services and Solutions
5.9.4 Counsyl Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.9.5 Counsyl Recent Developments
5.10 Eurofins NTD
5.10.1 Eurofins NTD Profile
5.10.2 Eurofins NTD Main Business
5.10.3 Eurofins NTD Prenatal Screening Products, Services and Solutions
5.10.4 Eurofins NTD Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.10.5 Eurofins NTD Recent Developments
5.11 Premaitha Health
5.11.1 Premaitha Health Profile
5.11.2 Premaitha Health Main Business
5.11.3 Premaitha Health Prenatal Screening Products, Services and Solutions
5.11.4 Premaitha Health Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.11.5 Premaitha Health Recent Developments
5.12 Prenatal Paternities
5.12.1 Prenatal Paternities Profile
5.12.2 Prenatal Paternities Main Business
5.12.3 Prenatal Paternities Prenatal Screening Products, Services and Solutions
5.12.4 Prenatal Paternities Prenatal Screening Revenue (US$ Million) & (2018-2023)
5.12.5 Prenatal Paternities Recent Developments
6 North America
6.1 North America Prenatal Screening Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prenatal Screening Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Screening Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prenatal Screening Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Screening Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prenatal Screening Market Dynamics
11.1 Prenatal Screening Industry Trends
11.2 Prenatal Screening Market Drivers
11.3 Prenatal Screening Market Challenges
11.4 Prenatal Screening Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
